PD-L1 expression best predicts response to atezolizumab + nab-paclitaxel for mTNBCDecember 5, 2018Breast CancerImmuno-oncology
Similarity of CT-P6 and trastuzumab remain with longer follow-upDecember 5, 2018Breast CancerPractice Management
SRS beats surgery in early control of brain mets, advantage fades with timeNovember 9, 2018CNS/Brain CancerBreast CancerMelanomaGastroenterologyGenitourinary CancerRenal Cell CarcinomaGastrointestinal Cancer
Circulating tumor DNA identified by fragment sizeNovember 7, 2018Gynecologic CancerGenitourinary CancerBreast CancerRenal Cell CarcinomaCNS/Brain CancerMelanoma
